Assessment of the scope and practice of evaluation among medical donation programs.
Medical donation programs for drugs, other medical products, training and other supportive services can improve access to essential medicines in low- and middle-income countries (LMICs) and provide emergency and disaster relief. The scope and extent to which medical donation programs evaluate their impact on recipients and health systems is not well documented.



We conducted a survey of the member organizations of the Partnership for Quality Medical Donations (PQMD), a global alliance of non-profit and corporate organizations, to identify evaluations conducted in conjunction with donation programs.



Twenty-five out of the 36 PQMD organizations that were members at the time of the survey participated in the study, for a response rate of 69 %. PQMD members provided information on 34 of their major medical donation programs. Half of the donation programs reported conducting trainings as a part of their donation program. Twenty-six (76 %) programs reported that they conduct routine monitoring of their donation programs. Less than 30 % of donation programs were evaluated for their impact on health. Lack of technical staff and lack of funding were reported as key barriers to conducting impact evaluations.



Member organizations of PQMD provide a broad range of medical donations, targeting a wide range of public health issues and events. While some level of monitoring and evaluation was conducted in nearly 80 % of the donation programs, a program's impact was infrequently evaluated. Opportunities exist to develop consistent metrics for medical donation programs, develop a common framework for impact evaluations, and advocate for data collection and analysis plans that collect meaningful metrics.
Department of Global Health, Global Medicines Program, University of Washington, Harris Hydraulics Building, Room 321, 1705 NE Pacific St., Box 357965, Seattle, WA, 98195-7965, USA. ajenny@uw.edu.
Alisa M
AM
Jenny
Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA.
Meng
M
Li
Partnership for Quality Medical Donations, Annapolis, MD, USA.
Elizabeth
E
Ashbourne
Pacific Links LLC, Grand Rapids, MI, USA.
Myron
M
Aldrink
Merck, Kenilworth, NJ, USA.
Christine
C
Funk
Department of Global Health, Global Medicines Program, University of Washington, Harris Hydraulics Building, Room 321, 1705 NE Pacific St., Box 357965, Seattle, WA, 98195-7965, USA.|Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA.
Andy
A
Stergachis
D003299:Cooperative Behavior; D003906:Developing Countries; D004864:Equipment and Supplies / Q000600:supply & distribution*; D005378:Financial Support; D006801:Humans; D017149:Private Sector / Q000191:economics / Q000639:trends; D015397:Program Evaluation / Q000379:methods*; D011795:Surveys and Questionnaires
Evaluation; Impact; Low- and Middle-Income Countries; Medical Donations; Monitoring; Neglected Tropical Diseases